OpenURL Connection Search

Select item for more details and to access through your institution.

Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer.
Published in:
Breast Cancer Research & Treatment, 2023, v. 200, n. 2, p. 271, doi. 10.1007/s10549-023-06965-5
By:
- Bos, M. K.;
- Lam, S. W.;
- Motta, G.;
- Helmijr, J. C. A.;
- Beaufort, C. M.;
- de Jonge, E.;
- Martens, J. W. M.;
- Boven, E.;
- Jansen, M. P. H. M.;
- Jager, A.;
- Sleijfer, S.
Publication type:
Article
The Price of Success: Cost-Effectiveness of Molecularly Targeted Agents.
Published in:
Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 136, doi. 10.1038/clpt.2008.245
By:
- Sleijfer, S.;
- Verweij, J.
Publication type:
Article
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry.
Published in:
2016
By:
- De Groot, S.;
- Sleijfer, S.;
- Redekop, W. K.;
- Oosterwijk, E.;
- Haanen, J. B. A. G.;
- Kiemeney, L. A. L. M.;
- Uyl-de Groot, C. A.
Publication type:
journal article
Influence of pegylated interferon-α therapy on plasma levels of citrulline and arginine in melanoma patients.
Published in:
Amino Acids, 2007, v. 32, n. 1, p. 121
By:
- M. Bannink;
- W. H. J. Kruit;
- A. R. Van Gool;
- P. G. H. Mulder;
- S. Sleijfer;
- A. M. M. Eggermont;
- G. Stoter
Publication type:
Article
Outcomes of First-Line Chemotherapy in Patients with Advanced or Metastatic Leiomyosarcoma of Uterine and Non-Uterine Origin.
Published in:
Sarcoma, 2009, v. 2009, p. 1, doi. 10.1155/2009/348910
By:
- Oosten, A. W.;
- Seynaeve, C.;
- Schmitz, P. I. M.;
- Den Bakker, M. A.;
- Verweij, J.;
- Sleijfer, S.
Publication type:
Article
Induction of tumor necrosis factor-alpha as a cause of bleomycin-related toxicity.
Published in:
1998
By:
- Sleijfer, S;
- Vujaskovic, Z;
- Limburg, P C;
- Schraffordt Koops, H;
- Mulder, N H
Publication type:
journal article
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer.
Published in:
Breast Cancer Research & Treatment, 2012, v. 133, n. 3, p. 937, doi. 10.1007/s10549-011-1877-4
By:
- Jansen, M.;
- Reijm, E.;
- Sieuwerts, A.;
- Ruigrok-Ritstier, K.;
- Look, M.;
- Rodríguez-González, F.;
- Heine, A.;
- Martens, J.;
- Sleijfer, S.;
- Foekens, J.;
- Berns, E.
Publication type:
Article
Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.
Published in:
Breast Cancer Research & Treatment, 2011, v. 125, n. 2, p. 387, doi. 10.1007/s10549-010-0836-9
By:
- Reijm, E.;
- Jansen, M.;
- Ruigrok-Ritstier, K.;
- Staveren, I.;
- Look, M.;
- Gelder, M.;
- Sieuwerts, A.;
- Sleijfer, S.;
- Foekens, J.;
- Berns, E.
Publication type:
Article
Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.697572
By:
- de Kruijff, I. E.;
- Sieuwerts, A. M.;
- Beije, N.;
- Prager - van der Smissen, W. J. C.;
- Angus, L.;
- Beaufort, C. M.;
- Van, M. N.;
- Oomen - de Hoop, E.;
- Jager, A.;
- Hamberg, P.;
- de Jongh, F. E.;
- Kraan, J.;
- Martens, J. W. M.;
- Sleijfer, S.
Publication type:
Article
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
Published in:
2021
By:
- Mulder, E. E. A. P.;
- de Joode, K.;
- Litière, S.;
- ten Tije, A. J.;
- Suijkerbuijk, K. P. M.;
- Boers-Sonderen, M. J.;
- Hospers, G. A. P.;
- de Groot, J. W. B.;
- van den Eertwegh, A. J. M.;
- Aarts, M. J. B.;
- Piersma, D.;
- van Rijn, R. S.;
- Kapiteijn, E.;
- Vreugdenhil, G.;
- van den Berkmortel, F. W. P. J.;
- Hoop, E. Oomen-de;
- Franken, M. G.;
- Ryll, B.;
- Rutkowski, P.;
- Sleijfer, S.
Publication type:
journal article
Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases.
Published in:
Clinical & Experimental Metastasis, 2023, v. 40, n. 1, p. 69, doi. 10.1007/s10585-022-10191-6
By:
- Meyer, Y. M.;
- Wilting, S. M.;
- Kraan, J.;
- Olthof, P.;
- Vermeulen, P.;
- Martens, J.;
- Grünhagen, D. J.;
- Sleijfer, S.;
- Verhoef, C.
Publication type:
Article
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial.
Published in:
British Journal of Cancer, 2015, v. 113, n. 2, p. 226, doi. 10.1038/bjc.2015.191
By:
- Beije, N;
- Kraan, J;
- Taal, W;
- van der Holt, B;
- Oosterkamp, H M;
- Walenkamp, A M;
- Beerepoot, L;
- Hanse, M;
- van Linde, M E;
- Otten, A;
- Vernhout, R M;
- de Vos, F Y F;
- Gratama, J W;
- Sleijfer, S;
- van den Bent, M J
Publication type:
Article
Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
Published in:
British Journal of Cancer, 2015, v. 112, n. 12, p. 1911, doi. 10.1038/bjc.2015.92
By:
- Sideras, K;
- Bots, S J;
- Biermann, K;
- Sprengers, D;
- Polak, W G;
- IJzermans, J N M;
- de Man, R A;
- Pan, Q;
- Sleijfer, S;
- Bruno, M J;
- Kwekkeboom, J
Publication type:
Article
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors.
Published in:
British Journal of Cancer, 2015, v. 112, n. 6, p. 1011, doi. 10.1038/bjc.2015.82
By:
- Kloth, J S L;
- Pagani, A;
- Verboom, M C;
- Malovini, A;
- Napolitano, C;
- Kruit, W H J;
- Sleijfer, S;
- Steeghs, N;
- Zambelli, A;
- Mathijssen, R H J
Publication type:
Article
Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases.
Published in:
British Journal of Cancer, 2015, v. 112, n. 3, p. 556, doi. 10.1038/bjc.2014.651
By:
- Lalmahomed, Z S;
- Mostert, B;
- Onstenk, W;
- Kraan, J;
- Ayez, N;
- Gratama, J W;
- Grünhagen, D;
- Verhoef, C;
- Sleijfer, S
Publication type:
Article
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors.
Published in:
2015
By:
- Kloth, J S L;
- Pagani, A;
- Verboom, M C;
- Malovini, A;
- Napolitano, C;
- Kruit, W H J;
- Sleijfer, S;
- Steeghs, N;
- Zambelli, A;
- Mathijssen, R H J
Publication type:
journal article
Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells.
Published in:
British Journal of Cancer, 2014, v. 111, n. 1, p. 149, doi. 10.1038/bjc.2014.286
By:
- Kraan, J;
- van den Broek, P;
- Verhoef, C;
- Grunhagen, D J;
- Taal, W;
- Gratama, J W;
- Sleijfer, S
Publication type:
Article
Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells.
Published in:
2014
By:
- Kraan, J;
- van den Broek, P;
- Verhoef, C;
- Grunhagen, D J;
- Taal, W;
- Gratama, J W;
- Sleijfer, S
Publication type:
journal article
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2014, v. 110, n. 10, p. 2441, doi. 10.1038/bjc.2014.194
By:
- Lankheet, N A G;
- Kloth, J S L;
- Gadellaa-van Hooijdonk, C G M;
- Cirkel, G A;
- Mathijssen, R H J;
- Lolkema, M P J K;
- Schellens, J H M;
- Voest, E E;
- Sleijfer, S;
- de Jonge, M J A;
- Haanen, J B A G;
- Beijnen, J H;
- Huitema, A D R;
- Steeghs, N
Publication type:
Article
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study.
Published in:
British Journal of Cancer, 2014, v. 110, n. 4, p. 888, doi. 10.1038/bjc.2013.798
By:
- Hamberg, P;
- Boers-Sonderen, M J;
- van der Graaf, W T A;
- de Bruijn, P;
- Suttle, A B;
- Eskens, F A L M;
- Verweij, J;
- van Herpen, C M L;
- Sleijfer, S
Publication type:
Article
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Published in:
2013
By:
- Gits, C M M;
- van Kuijk, P F;
- Jonkers, M B E;
- Boersma, A W M;
- van Ijcken, W F;
- Wozniak, A;
- Sciot, R;
- Rutkowski, P;
- Schöffski, P;
- Taguchi, T;
- Mathijssen, R H J;
- Verweij, J;
- Sleijfer, S;
- Debiec-Rychter, M;
- Wiemer, E A C
Publication type:
journal article
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Published in:
British Journal of Cancer, 2013, v. 109, n. 6, p. 1625, doi. 10.1038/bjc.2013.483
By:
- Gits, C M M;
- van Kuijk, P F;
- Jonkers, M B E;
- Boersma, A W M;
- van IJcken, W F;
- Wozniak, A;
- Sciot, R;
- Rutkowski, P;
- Schöffski, P;
- Taguchi, T;
- Mathijssen, R H J;
- Verweij, J;
- Sleijfer, S;
- Debiec-Rychter, M;
- Wiemer, E A C
Publication type:
Article
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.
Published in:
British Journal of Cancer, 2012, v. 107, n. 6, p. 947, doi. 10.1038/bjc.2012.351
By:
- Godinho, M F E;
- Wulfkuhle, J D;
- Look, M P;
- Sieuwerts, A M;
- Sleijfer, S;
- Foekens, J A;
- Petricoin, E F;
- Dorssers, L C J;
- van Agthoven, T
Publication type:
Article
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study.
Published in:
British Journal of Cancer, 2012, v. 107, n. 4, p. 639, doi. 10.1038/bjc.2012.328
By:
- Sleijfer, S;
- Gorlia, T;
- Lamers, C;
- Burger, H;
- Blay, J-Y;
- Le Cesne, A;
- Scurr, M;
- Collin, F;
- Pandite, L;
- Marreaud, S;
- Hohenberger, P
Publication type:
Article
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study.
Published in:
2011
By:
- Penel, N.;
- Glabbeke, M. V.;
- Mathoulin-Pelissier, S.;
- Judson, I.;
- Sleijfer, S.;
- Bui, B.;
- Schoffski, P.;
- Ouali, M.;
- Marreaud, S.;
- Brouste, V.;
- Duhamel, A.;
- Hohenberger, P.;
- Blay, J.-Y.
Publication type:
journal article
Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies.
Published in:
2010
By:
- Hamberg, P.;
- Steeghs, N.;
- Loos, W. J.;
- van de Biessen, D.;
- den Hollander, M.;
- Tascilar, M.;
- Verweij, J.;
- Gelderblom, H.;
- Sleijfer, S.
Publication type:
journal article
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
Published in:
2009
By:
- van Agthoven, T.;
- Sieuwerts, A. M.;
- Veldscholte, J.;
- Meijer-van Gelder, M. E.;
- Smid, M.;
- Brinkman, A.;
- den Dekker, A. T.;
- Leroy, I. M.;
- van IJcken, W. F. J.;
- Sleijfer, S.;
- Foekens, J. A.;
- Dorssers, L. C. J.
Publication type:
journal article
'It's the Economy, Stupid': Strategies for Improved Cost Containment in Cancer Treatment.
Published in:
Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 4, p. 365, doi. 10.1038/clpt.2014.9
By:
- Sleijfer, S
Publication type:
Article
Retroviral vectors for clinical immunogene therapy are stable for up to 9 years.
Published in:
Cancer Gene Therapy, 2008, v. 15, n. 4, p. 268, doi. 10.1038/sj.cgt.7701114
By:
- Lamers, C. H. J.;
- van Elzakker, P.;
- Luider, B. A.;
- van Steenbergen, S. C. L.;
- Sleijfer, S.;
- Debets, R.;
- Gratama, J. W.
Publication type:
Article
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 365, doi. 10.1007/s00280-014-2655-x
By:
- Hamberg, P.;
- Mathijssen, R.;
- Bruijn, P.;
- Leonowens, C.;
- Biessen, D.;
- Eskens, F.;
- Sleijfer, S.;
- Verweij, J.;
- Jonge, M.
Publication type:
Article
Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.
Published in:
2009
By:
- Konings IR;
- Engels FK;
- Sleijfer S;
- Verweij J;
- Wiemer EA;
- Loos WJ;
- Konings, Inge R H M;
- Engels, Frederike K;
- Sleijfer, Stefan;
- Verweij, Jaap;
- Wiemer, Erik A C;
- Loos, Walter J
Publication type:
journal article
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.
Published in:
Acta Oncologica, 2017, v. 56, n. 1, p. 88, doi. 10.1080/0284186X.2016.1234068
By:
- Kollár, A.;
- Duffaud, F.;
- Sleijfer, S.;
- Touati, N.;
- Litière, S.;
- Marreaud, S.;
- Gronchi, A.;
- Kasper, B.;
- Jones, R. L.;
- van der Graaf, W. T.;
- Stacchiotti, S.;
- Gelderblom, H.;
- Guida, M.;
- Grignani, G.;
- Steeghs, N.;
- Safwat, A.;
- Katz, D.
Publication type:
Article
Editorial: The long and winding road to better cancer cell-specific therapies.
Published in:
2008
By:
- Sleijfer S;
- Wiemer E
Publication type:
Journal Article
Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.
Published in:
2018
By:
- de Groot, S.;
- Redekop, W. K.;
- Versteegh, M. M.;
- Sleijfer, S.;
- Oosterwijk, E.;
- Kiemeney, L. A. L. M.;
- Uyl-de Groot, C. A.
Publication type:
journal article
De rol van circulerende tumorcellen bij het urotheelcarcinoom van de blaas.
Published in:
Tijdschrift voor Urologie, 2015, v. 5, n. 8, p. 223, doi. 10.1007/s13629-015-0101-4
By:
- Beije, N.;
- Sleijfer, S.;
- Boormans, J.L.
Publication type:
Article
Circulating endothelial cells in oncology: pitfalls and promises.
Published in:
2008
By:
- Strijbos, M. H.;
- Gratama, J. W.;
- Kraan, J.;
- Lamers, C. H.;
- den Bakker, M. A.;
- Sleijfer, S.
Publication type:
journal article
<sup>89</sup>Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 13, p. 2300, doi. 10.1007/s00259-018-4099-8
By:
- Bensch, Frederike;
- de Vries, E. G. E.;
- Schröder, C. P.;
- Brouwers, A. H.;
- Lub-de Hooge, M. N.;
- de Jong, J. R.;
- van der Vegt, B.;
- Sleijfer, S.
Publication type:
Article
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37764-z
By:
- de Joode, K.;
- van de Geer, W. S.;
- van Leenders, G. J. L. H.;
- Hamberg, P.;
- Westgeest, H. M.;
- Beeker, A.;
- Oosting, S. F.;
- van Rooijen, J. M.;
- Beerepoot, L. V.;
- Labots, M.;
- Mathijssen, R. H. J.;
- Lolkema, M. P.;
- Cuppen, E.;
- Sleijfer, S.;
- van de Werken, H. J. G.;
- van der Veldt, A. A. M.
Publication type:
Article
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.
Published in:
PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177364
By:
- De Groot, S.;
- Blommestein, H. M.;
- Redekop, W. K.;
- Sleijfer, S.;
- Kiemeney, L. A. L. M.;
- Oosterwijk, E.;
- Uyl-de Groot, C. A.
Publication type:
Article
mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy.
Published in:
Molecular Oncology, 2016, v. 10, n. 10, p. 1542, doi. 10.1016/j.molonc.2016.09.002
By:
- van der Stok, E.P.;
- Smid, M.;
- Sieuwerts, A.M.;
- Vermeulen, P.B.;
- Sleijfer, S.;
- Ayez, N.;
- Grünhagen, D.J.;
- Martens, J.W.M.;
- Verhoef, C.
Publication type:
Article
Radiomics approach to distinguish between well differentiated liposarcomas and lipomas on MRI.
Published in:
British Journal of Surgery, 2019, v. 106, n. 13, p. 1800, doi. 10.1002/bjs.11410
By:
- Vos, M.;
- Starmans, M. P. A.;
- Timbergen, M. J. M.;
- van der Voort, S. R.;
- Padmos, G. A.;
- Kessels, W.;
- Niessen, W. J.;
- van Leenders, G. J. L. H.;
- Grünhagen, D. J.;
- Sleijfer, S.;
- Verhoef, C.;
- Klein, S.;
- Visser, J. J.
Publication type:
Article

Found: 41